TE_6821

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L1HS_5end
TE superfamily L1
TE class LINE
Gene -
Class Intergenic
Coding Non-coding, Other
Tumor-specific score 220.23
Counts of samples TCGA_tumor:976; TCGA_normal:3; GTEx:1
TSS chr3(+):18936133



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_6821.41 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,19075965,19076080,19078880,19078934,19125733,19125805,19126386,19126466,19127013,19127142,19143051,19143147,19145048,19145068
teRNA_6821.42 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,19075965,19076080,19078883,19078934,19125735,19125805,19126386,19126466,19127013,19127033
teRNA_6821.43 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,19075965,19076080,19078880,19078934,19125735,19125805,19126386,19126466,19127013,19127033
teRNA_6821.44 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,18944668,18944814,18966293,18966407,19075965,19076080,19078883,19078903
teRNA_6821.45 - Intergenic Non-coding Non-coding chr3(+):18936134,18936522,18944668,18944688
teRNA_6821.46 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18936407,18936522,18966293,18966313
teRNA_6821.47 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18936407,18936522,18966293,18966407,19021376,19021503,19043270,19043290
teRNA_6821.48 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18936407,18936522,18966293,18966407,19043270,19043290
teRNA_6821.49 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18936407,18936522,18966293,18966407,19075965,19076080,19078883,19078934,19126386,19126466,19127013,19127142,19143051,19143071
teRNA_6821.50 - Intergenic Non-coding Non-coding chr3(+):18936134,18936261,18936407,18936522,18966293,18966407,19075965,19076080,19078883,19078934,19114239,19114259


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).